Hikal Limited has secured a multi-year contract with a Europe-based global agrochemical company. The agreement, signed by Hikal’s Crop Protection division, involves contract development and manufacturing (CDMO) of a specialized agrochemical product. Commercial launch is anticipated by the end of FY 2026-27, with volumes expected to grow progressively. This marks a significant milestone for Hikal’s Crop Protection business, leveraging its technical expertise and manufacturing capabilities for long-term growth.
Hikal Secures Key Global CDMO Contract
Hikal Limited announced today that it has signed a multi-year contract with a leading Europe-based global agrochemical company. This significant agreement, finalized by Hikal’s Crop Protection division, encompasses contract development and manufacturing (CDMO) for a specialized agrochemical product destined for worldwide markets.
Commercial Launch and Growth Prospects
The contract follows a period of successful process development and scale-up of the new product, positioning it as a key commercial milestone for Hikal’s Crop Protection business. The commercial launch of this product is expected towards the end of FY 2026-27. Hikal anticipates that volumes will grow progressively as regulatory approvals are secured across various global markets, underlining the expansive reach of this partnership.
Strategic Importance and Capabilities
This partnership underscores Hikal’s robust capabilities in process development and commercialisation, demonstrating its ability to translate intricate customer requirements into sustainable, long-term manufacturing opportunities. The agreement is set to strengthen Hikal’s Crop Protection business by broadening its portfolio of specialized offerings for its global clientele.
Chairman’s Commentary
Commenting on the development, Mr. Sameer Hiremath, Chairman & Managing Director, Hikal Limited, stated, “This contract marks an important milestone for our Crop Protection business, converting nearly three years of collaborative development and scale-up into a long-term commercial partnership. It demonstrates Hikal’s ability to combine deep technical expertise with reliable manufacturing capabilities to take complex products from development to commercial supply. We are well positioned to support the planned launch and progressive expansion of supplies across global markets.”
About Hikal Limited
Established in 1988, Hikal is a trusted partner across the Pharmaceutical, Animal Health, Biotech, Personal Care, and Specialty Chemical industries. The company manufactures and supplies quality Active Ingredients, Intermediates, and Biocides to the global life sciences industry. Hikal operates five manufacturing facilities in India and a world-class Research & Technology centre in Pune, all of which have been inspected and certified by Global Regulatory Authorities. Hikal is recognized for its commitment to inclusive growth, holding the Responsible Care® certification and an EcoVadis Gold Medal rating, placing it among the top 5% of companies globally for sustainability performance.
Source: BSE
